February 20-22, 2020 | New York Hilton Midtown, NY

Pre-Conference: Metagenics Institute

Coronary Heart Disease: Clinical Insight into a Silent Killer

Wednesday, February 19, 2020
Sponsored by:

On a global level, cardiovascular disease (CVD) accounts for 1 in 3 deaths and is the leading cause of death for both men and women. The most common type of heart disease in the United States is coronary heart disease.

Despite the statistics, the cardiovascular system remains underappreciated, often generating clinical attention only after a significant event, such as a stroke or heart attack.

Metagenics Institute, in collaboration with Dr. Mark Houston, invite you to get to the heart of the matter to better understand how to assess the cardiovascular health of your patients. Join us for a full day of education covering the most up-to-date, cutting-edge, and practical clinical information for both primary care physicians and specialists in the diagnosis, prevention, and treatment of cardiovascular disease. With a focus on vascular systems biology and dyslipidemia, topics will cover advanced lipid testing, sex differences, underlying causes of dyslipidemia and the role of personalized lifestyle medicine.

Topics discussed:

• Diagnosis, prevention, and treatment of cardiovascular disease
• Vascular systems biology and dyslipidemia
• Advanced lipid testing
• Sex differences in heart health
• Underlying causes of dyslipidemia
• The role of personalized lifestyle medicine for cardiovascular disease

View the Pre-Conference schedule here.

About the speaker:
Mark Houston, MD, MS, FAHA, FASH, DABC
 is a highly recognized cardiovascular and
hypertension specialist, serving as a physician at St. Thomas West Hospital in Nashville, where he
holds several leadership positions including Director of the Hypertension Institute and Vascular
Biology, Medical Director of Clinical Research, and Section Chief for the Division of Nutrition.
Dr. Houston cofounded the Hypertension Institute, which is one of the leading institutes in
the US for hypertension treatment. An American Society of Hypertension (ASH) specialist and
Diplomate of the American Board of Cardiology, Dr. Houston is also a Fellow of the American
Society of Hypertension (FASH), the American Heart Association (FAHA), Internal Medicine
(ABIM), American College of Nutrition (FACN) and Anti-Aging Medicine (ABAARM). Dr. Houston
received his medical degree from Vanderbilt University. He also obtained two master’s degrees,
in Human Nutrition and Metabolic Medicine and Human Nutrition, from the University of
Bridgeport and University of South Florida, respectively.

Register today!

© Diversified Communications. All rights reserved.